APO Research
Talk to an analyst

APO RESEARCH · REPORT

Etoposide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Etoposide Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchEtoposide Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Etoposide Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Etoposide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Etoposide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Etoposide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Etoposide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Etoposide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Etoposide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Etoposide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Etoposide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Etoposide include Teva Pharmaceutical, Qilu Antibiotics, Mylan, China Resources Double Crane Pharmaceutical, Shyndec Pharmaceutical, Nippon Kayaku, KPC Pharmaceuticals, Gansu Fuzheng and Accord Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Etoposide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Etoposide, also provides the sales of main regions and countries. Of the upcoming market potential for Etoposide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Etoposide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Etoposide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Etoposide sales, projected growth trends, production technology, application and end-user industry.

Etoposide Segment by Company

Teva Pharmaceutical

Qilu Antibiotics

Mylan

China Resources Double Crane Pharmaceutical

Shyndec Pharmaceutical

Nippon Kayaku

KPC Pharmaceuticals

Gansu Fuzheng

Accord Healthcare

Etoposide Segment by Type

Etoposide for Injection

Etoposide for Oral Use

Etoposide Segment by Application

Small Cell Lung Cancer

Testicular Cancer

Etoposide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Etoposide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Etoposide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Etoposide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Etoposide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Etoposide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Etoposide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Etoposide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Etoposide for Injection Major Manufacturers Table 3. Etoposide for Oral Use Major Manufacturers Table 4. Global Etoposide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Small Cell Lung Cancer Major Manufacturers Table 6. Testicular Cancer Major Manufacturers Table 7. Etoposide Industry Trends Table 8. Etoposide Industry Drivers Table 9. Etoposide Industry Opportunities and Challenges Table 10. Etoposide Industry Restraints Table 11. Global Etoposide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Etoposide Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Etoposide Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Etoposide Revenue Market Share by Region (2021-2026) Table 15. Global Etoposide Revenue Market Share by Region (2027-2032) Table 16. Global Etoposide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 17. Global Etoposide Sales by Region (2021-2026) & (units) Table 18. Global Etoposide Sales by Region (2027-2032) & (units) Table 19. Global Etoposide Sales Market Share by Region (2021-2026) Table 20. Global Etoposide Sales Market Share by Region (2027-2032) Table 21. Global Etoposide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Etoposide Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Etoposide Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Etoposide Sales Market Share by Manufacturers (2021-2026) Table 25. Global Etoposide Sales Price (k US$/unit) of Manufacturers (2021-2026) Table 26. Global Etoposide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Etoposide Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Etoposide Manufacturers, Product Type & Application Table 29. Global Etoposide Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Etoposide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Etoposide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Etoposide Revenue Market Share by Type (2021-2026) Table 36. Global Etoposide Revenue Market Share by Type (2027-2032) Table 37. Global Etoposide Sales by Type 2021 VS 2025 VS 2032 (units) Table 38. Global Etoposide Sales by Type (2021-2026) & (units) Table 39. Global Etoposide Sales by Type (2027-2032) & (units) Table 40. Global Etoposide Sales Market Share by Type (2021-2026) Table 41. Global Etoposide Sales Market Share by Type (2027-2032) Table 42. Global Etoposide Price by Type (2021-2026) & (k US$/unit) Table 43. Global Etoposide Price by Type (2027-2032) & (k US$/unit) Table 44. Global Etoposide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Etoposide Revenue Market Share by Application (2021-2026) Table 48. Global Etoposide Revenue Market Share by Application (2027-2032) Table 49. Global Etoposide Sales by Application 2021 VS 2025 VS 2032 (units) Table 50. Global Etoposide Sales by Application (2021-2026) & (units) Table 51. Global Etoposide Sales by Application (2027-2032) & (units) Table 52. Global Etoposide Sales Market Share by Application (2021-2026) Table 53. Global Etoposide Sales Market Share by Application (2027-2032) Table 54. Global Etoposide Price by Application (2021-2026) & (k US$/unit) Table 55. Global Etoposide Price by Application (2027-2032) & (k US$/unit) Table 56. Teva Pharmaceutical Company Information Table 57. Teva Pharmaceutical Business Overview Table 58. Teva Pharmaceutical Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 59. Teva Pharmaceutical Etoposide Product Portfolio Table 60. Teva Pharmaceutical Recent Development Table 61. Qilu Antibiotics Company Information Table 62. Qilu Antibiotics Business Overview Table 63. Qilu Antibiotics Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 64. Qilu Antibiotics Etoposide Product Portfolio Table 65. Qilu Antibiotics Recent Development Table 66. Mylan Company Information Table 67. Mylan Business Overview Table 68. Mylan Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 69. Mylan Etoposide Product Portfolio Table 70. Mylan Recent Development Table 71. China Resources Double Crane Pharmaceutical Company Information Table 72. China Resources Double Crane Pharmaceutical Business Overview Table 73. China Resources Double Crane Pharmaceutical Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 74. China Resources Double Crane Pharmaceutical Etoposide Product Portfolio Table 75. China Resources Double Crane Pharmaceutical Recent Development Table 76. Shyndec Pharmaceutical Company Information Table 77. Shyndec Pharmaceutical Business Overview Table 78. Shyndec Pharmaceutical Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 79. Shyndec Pharmaceutical Etoposide Product Portfolio Table 80. Shyndec Pharmaceutical Recent Development Table 81. Nippon Kayaku Company Information Table 82. Nippon Kayaku Business Overview Table 83. Nippon Kayaku Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 84. Nippon Kayaku Etoposide Product Portfolio Table 85. Nippon Kayaku Recent Development Table 86. KPC Pharmaceuticals Company Information Table 87. KPC Pharmaceuticals Business Overview Table 88. KPC Pharmaceuticals Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 89. KPC Pharmaceuticals Etoposide Product Portfolio Table 90. KPC Pharmaceuticals Recent Development Table 91. Gansu Fuzheng Company Information Table 92. Gansu Fuzheng Business Overview Table 93. Gansu Fuzheng Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 94. Gansu Fuzheng Etoposide Product Portfolio Table 95. Gansu Fuzheng Recent Development Table 96. Accord Healthcare Company Information Table 97. Accord Healthcare Business Overview Table 98. Accord Healthcare Etoposide Sales (units), Revenue (US$ Million), Price (k US$/unit) and Gross Margin (2021-2026) Table 99. Accord Healthcare Etoposide Product Portfolio Table 100. Accord Healthcare Recent Development Table 101. North America Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Etoposide Sales by Type (2021-2026) & (units) Table 104. North America Etoposide Sales by Type (2027-2032) & (units) Table 105. North America Etoposide Sales Price by Type (2021-2026) & (k US$/unit) Table 106. North America Etoposide Sales Price by Type (2027-2032) & (k US$/unit) Table 107. North America Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Etoposide Sales by Application (2021-2026) & (units) Table 110. North America Etoposide Sales by Application (2027-2032) & (units) Table 111. North America Etoposide Sales Price by Application (2021-2026) & (k US$/unit) Table 112. North America Etoposide Sales Price by Application (2027-2032) & (k US$/unit) Table 113. North America Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Etoposide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Etoposide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Etoposide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 117. North America Etoposide Sales by Country (2021-2026) & (units) Table 118. North America Etoposide Sales by Country (2027-2032) & (units) Table 119. North America Etoposide Sales Price by Country (2021-2026) & (k US$/unit) Table 120. North America Etoposide Sales Price by Country (2027-2032) & (k US$/unit) Table 121. United States Etoposide Revenue (2021-2032) & (US$ Million) Table 122. Canada Etoposide Revenue (2021-2032) & (US$ Million) Table 123. Mexico Etoposide Revenue (2021-2032) & (US$ Million) Table 124. Europe Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Etoposide Sales by Type (2021-2026) & (units) Table 127. Europe Etoposide Sales by Type (2027-2032) & (units) Table 128. Europe Etoposide Sales Price by Type (2021-2026) & (k US$/unit) Table 129. Europe Etoposide Sales Price by Type (2027-2032) & (k US$/unit) Table 130. Europe Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Etoposide Sales by Application (2021-2026) & (units) Table 133. Europe Etoposide Sales by Application (2027-2032) & (units) Table 134. Europe Etoposide Sales Price by Application (2021-2026) & (k US$/unit) Table 135. Europe Etoposide Sales Price by Application (2027-2032) & (k US$/unit) Table 136. Europe Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Etoposide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Etoposide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Etoposide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 140. Europe Etoposide Sales by Country (2021-2026) & (units) Table 141. Europe Etoposide Sales by Country (2027-2032) & (units) Table 142. Europe Etoposide Sales Price by Country (2021-2026) & (k US$/unit) Table 143. Europe Etoposide Sales Price by Country (2027-2032) & (k US$/unit) Table 144. Germany Etoposide Revenue (2021-2032) & (US$ Million) Table 145. France Etoposide Revenue (2021-2032) & (US$ Million) Table 146. U.K. Etoposide Revenue (2021-2032) & (US$ Million) Table 147. Italy Etoposide Revenue (2021-2032) & (US$ Million) Table 148. Russia Etoposide Revenue (2021-2032) & (US$ Million) Table 149. Spain Etoposide Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Etoposide Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Etoposide Revenue (2021-2032) & (US$ Million) Table 152. Sweden Etoposide Revenue (2021-2032) & (US$ Million) Table 153. Poland Etoposide Revenue (2021-2032) & (US$ Million) Table 154. China Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 155. China Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 156. China Etoposide Sales by Type (2021-2026) & (units) Table 157. China Etoposide Sales by Type (2027-2032) & (units) Table 158. China Etoposide Sales Price by Type (2021-2026) & (k US$/unit) Table 159. China Etoposide Sales Price by Type (2027-2032) & (k US$/unit) Table 160. China Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 161. China Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 162. China Etoposide Sales by Application (2021-2026) & (units) Table 163. China Etoposide Sales by Application (2027-2032) & (units) Table 164. China Etoposide Sales Price by Application (2021-2026) & (k US$/unit) Table 165. China Etoposide Sales Price by Application (2027-2032) & (k US$/unit) Table 166. Asia Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Etoposide Sales by Type (2021-2026) & (units) Table 169. Asia Etoposide Sales by Type (2027-2032) & (units) Table 170. Asia Etoposide Sales Price by Type (2021-2026) & (k US$/unit) Table 171. Asia Etoposide Sales Price by Type (2027-2032) & (k US$/unit) Table 172. Asia Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Etoposide Sales by Application (2021-2026) & (units) Table 175. Asia Etoposide Sales by Application (2027-2032) & (units) Table 176. Asia Etoposide Sales Price by Application (2021-2026) & (k US$/unit) Table 177. Asia Etoposide Sales Price by Application (2027-2032) & (k US$/unit) Table 178. Asia Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Etoposide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Etoposide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Etoposide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 182. Asia Etoposide Sales by Country (2021-2026) & (units) Table 183. Asia Etoposide Sales by Country (2027-2032) & (units) Table 184. Asia Etoposide Sales Price by Country (2021-2026) & (k US$/unit) Table 185. Asia Etoposide Sales Price by Country (2027-2032) & (k US$/unit) Table 186. Japan Etoposide Revenue (2021-2032) & (US$ Million) Table 187. South Korea Etoposide Revenue (2021-2032) & (US$ Million) Table 188. India Etoposide Revenue (2021-2032) & (US$ Million) Table 189. Australia Etoposide Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Etoposide Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Etoposide Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Etoposide Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Etoposide Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Etoposide Sales by Type (2021-2026) & (units) Table 195. SAMEA Etoposide Sales by Type (2027-2032) & (units) Table 196. SAMEA Etoposide Sales Price by Type (2021-2026) & (k US$/unit) Table 197. SAMEA Etoposide Sales Price by Type (2027-2032) & (k US$/unit) Table 198. SAMEA Etoposide Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Etoposide Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Etoposide Sales by Application (2021-2026) & (units) Table 201. SAMEA Etoposide Sales by Application (2027-2032) & (units) Table 202. SAMEA Etoposide Sales Price by Application (2021-2026) & (k US$/unit) Table 203. SAMEA Etoposide Sales Price by Application (2027-2032) & (k US$/unit) Table 204. SAMEA Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Etoposide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Etoposide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Etoposide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 208. SAMEA Etoposide Sales by Country (2021-2026) & (units) Table 209. SAMEA Etoposide Sales by Country (2027-2032) & (units) Table 210. SAMEA Etoposide Sales Price by Country (2021-2026) & (k US$/unit) Table 211. SAMEA Etoposide Sales Price by Country (2027-2032) & (k US$/unit) Table 212. Brazil Etoposide Revenue (2021-2032) & (US$ Million) Table 213. Argentina Etoposide Revenue (2021-2032) & (US$ Million) Table 214. Chile Etoposide Revenue (2021-2032) & (US$ Million) Table 215. Colombia Etoposide Revenue (2021-2032) & (US$ Million) Table 216. Peru Etoposide Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Etoposide Revenue (2021-2032) & (US$ Million) Table 218. Israel Etoposide Revenue (2021-2032) & (US$ Million) Table 219. UAE Etoposide Revenue (2021-2032) & (US$ Million) Table 220. Turkey Etoposide Revenue (2021-2032) & (US$ Million) Table 221. Iran Etoposide Revenue (2021-2032) & (US$ Million) Table 222. Egypt Etoposide Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Etoposide Distributors List Table 226. Etoposide Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Etoposide Image Figure 2. Global Etoposide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Etoposide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Etoposide for Injection Image Figure 5. Etoposide for Oral Use Image Figure 6. Global Etoposide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Etoposide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Small Cell Lung Cancer Image Figure 9. Testicular Cancer Image Figure 10. Global Etoposide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Etoposide Revenue (2021-2032) & (US$ Million) Figure 12. Global Etoposide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Etoposide Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Etoposide Revenue Market Share by Region (2021-2032) Figure 15. Global Etoposide Sales (2021-2032) & (units) Figure 16. Global Etoposide Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 17. Global Etoposide Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Etoposide Sales YoY (2021-2032) & (units) Figure 19. Europe Etoposide Sales YoY (2021-2032) & (units) Figure 20. China Etoposide Sales YoY (2021-2032) & (units) Figure 21. Asia (Excluding China) Etoposide Sales YoY (2021-2032) & (units) Figure 22. South America, Middle East and Africa Etoposide Sales YoY (2021-2032) & (units) Figure 23. Global Etoposide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Etoposide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Etoposide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Etoposide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Etoposide Revenue Market Share by Type (2021-2032) Figure 29. Global Etoposide Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 30. Global Etoposide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Etoposide Sales Market Share by Type (2021-2032) Figure 32. Global Etoposide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Etoposide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Etoposide Revenue Market Share by Application (2021-2032) Figure 35. Global Etoposide Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 36. Global Etoposide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Etoposide Sales Market Share by Application (2021-2032) Figure 38. North America Etoposide Revenue Share by Type (2021-2032) Figure 39. North America Etoposide Sales Share by Type (2021-2032) Figure 40. North America Etoposide Revenue Share by Application (2021-2032) Figure 41. North America Etoposide Sales Share by Application (2021-2032) Figure 42. North America Etoposide Revenue Share by Country (2021-2032) Figure 43. North America Etoposide Sales Share by Country (2021-2032) Figure 44. Europe Etoposide Revenue Share by Type (2021-2032) Figure 45. Europe Etoposide Sales Share by Type (2021-2032) Figure 46. Europe Etoposide Revenue Share by Application (2021-2032) Figure 47. Europe Etoposide Sales Share by Application (2021-2032) Figure 48. Europe Etoposide Revenue Share by Country (2021-2032) Figure 49. Europe Etoposide Sales Share by Country (2021-2032) Figure 50. China Etoposide Revenue Share by Type (2021-2032) Figure 51. China Etoposide Sales Share by Type (2021-2032) Figure 52. China Etoposide Revenue Share by Application (2021-2032) Figure 53. China Etoposide Sales Share by Application (2021-2032) Figure 54. Asia Etoposide Revenue Share by Type (2021-2032) Figure 55. Asia Etoposide Sales Share by Type (2021-2032) Figure 56. Asia Etoposide Revenue Share by Application (2021-2032) Figure 57. Asia Etoposide Sales Share by Application (2021-2032) Figure 58. Asia Etoposide Revenue Share by Country (2021-2032) Figure 59. Asia Etoposide Sales Share by Country (2021-2032) Figure 60. SAMEA Etoposide Revenue Share by Type (2021-2032) Figure 61. SAMEA Etoposide Sales Share by Type (2021-2032) Figure 62. SAMEA Etoposide Revenue Share by Application (2021-2032) Figure 63. SAMEA Etoposide Sales Share by Application (2021-2032) Figure 64. SAMEA Etoposide Revenue Share by Country (2021-2032) Figure 65. SAMEA Etoposide Sales Share by Country (2021-2032) Figure 66. Etoposide Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Etoposide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Etoposide for Injection
  • Etoposide for Oral Use
Applications
  • Small Cell Lung Cancer
  • Testicular Cancer
Companies covered
  • Teva Pharmaceutical
  • Qilu Antibiotics
  • Mylan
  • China Resources Double Crane Pharmaceutical
  • Shyndec Pharmaceutical
  • Nippon Kayaku
  • KPC Pharmaceuticals
  • Gansu Fuzheng
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Etoposide Market by Type
  3. 1.2.1 Global Etoposide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Etoposide for Injection
  5. 1.2.3 Etoposide for Oral Use
  6. 1.3 Etoposide Market by Application
  7. 1.3.1 Global Etoposide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Small Cell Lung Cancer
  9. 1.3.3 Testicular Cancer
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Etoposide Market Dynamics
  1. 2.1 Etoposide Industry Trends
  2. 2.2 Etoposide Industry Drivers
  3. 2.3 Etoposide Industry Opportunities and Challenges
  4. 2.4 Etoposide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Etoposide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Etoposide Revenue by Region
  3. 3.2.1 Global Etoposide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Etoposide Revenue by Region (2021-2026)
  5. 3.2.3 Global Etoposide Revenue by Region (2027-2032)
  6. 3.2.4 Global Etoposide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Etoposide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Etoposide Sales by Region
  9. 3.4.1 Global Etoposide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Etoposide Sales by Region (2021-2026)
  11. 3.4.3 Global Etoposide Sales by Region (2027-2032)
  12. 3.4.4 Global Etoposide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Etoposide Revenue by Manufacturers
  2. 4.1.1 Global Etoposide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Etoposide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Etoposide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Etoposide Sales by Manufacturers
  6. 4.2.1 Global Etoposide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Etoposide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Etoposide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Etoposide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Etoposide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Etoposide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Etoposide Manufacturers, Product Type & Application
  13. 4.7 Global Etoposide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Etoposide Market CR5 and HHI
  16. 4.8.2 2025 Etoposide Tier 1, Tier 2, and Tier 3
5 Etoposide Market by Type
  1. 5.1 Global Etoposide Revenue by Type
  2. 5.1.1 Global Etoposide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Etoposide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Etoposide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Etoposide Sales by Type
  6. 5.2.1 Global Etoposide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Etoposide Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Etoposide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Etoposide Price by Type
6 Etoposide Market by Application
  1. 6.1 Global Etoposide Revenue by Application
  2. 6.1.1 Global Etoposide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Etoposide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Etoposide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Etoposide Sales by Application
  6. 6.2.1 Global Etoposide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Etoposide Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Etoposide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Etoposide Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Etoposide Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Qilu Antibiotics
  8. 7.2.1 Qilu Antibiotics Company Information
  9. 7.2.2 Qilu Antibiotics Business Overview
  10. 7.2.3 Qilu Antibiotics Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qilu Antibiotics Etoposide Product Portfolio
  12. 7.2.5 Qilu Antibiotics Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Etoposide Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 China Resources Double Crane Pharmaceutical
  20. 7.4.1 China Resources Double Crane Pharmaceutical Company Information
  21. 7.4.2 China Resources Double Crane Pharmaceutical Business Overview
  22. 7.4.3 China Resources Double Crane Pharmaceutical Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 China Resources Double Crane Pharmaceutical Etoposide Product Portfolio
  24. 7.4.5 China Resources Double Crane Pharmaceutical Recent Developments
  25. 7.5 Shyndec Pharmaceutical
  26. 7.5.1 Shyndec Pharmaceutical Company Information
  27. 7.5.2 Shyndec Pharmaceutical Business Overview
  28. 7.5.3 Shyndec Pharmaceutical Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shyndec Pharmaceutical Etoposide Product Portfolio
  30. 7.5.5 Shyndec Pharmaceutical Recent Developments
  31. 7.6 Nippon Kayaku
  32. 7.6.1 Nippon Kayaku Company Information
  33. 7.6.2 Nippon Kayaku Business Overview
  34. 7.6.3 Nippon Kayaku Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Nippon Kayaku Etoposide Product Portfolio
  36. 7.6.5 Nippon Kayaku Recent Developments
  37. 7.7 KPC Pharmaceuticals
  38. 7.7.1 KPC Pharmaceuticals Company Information
  39. 7.7.2 KPC Pharmaceuticals Business Overview
  40. 7.7.3 KPC Pharmaceuticals Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 KPC Pharmaceuticals Etoposide Product Portfolio
  42. 7.7.5 KPC Pharmaceuticals Recent Developments
  43. 7.8 Gansu Fuzheng
  44. 7.8.1 Gansu Fuzheng Company Information
  45. 7.8.2 Gansu Fuzheng Business Overview
  46. 7.8.3 Gansu Fuzheng Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Gansu Fuzheng Etoposide Product Portfolio
  48. 7.8.5 Gansu Fuzheng Recent Developments
  49. 7.9 Accord Healthcare
  50. 7.9.1 Accord Healthcare Company Information
  51. 7.9.2 Accord Healthcare Business Overview
  52. 7.9.3 Accord Healthcare Etoposide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Accord Healthcare Etoposide Product Portfolio
  54. 7.9.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Etoposide Market Size by Type
  2. 8.1.1 North America Etoposide Revenue by Type (2021-2032)
  3. 8.1.2 North America Etoposide Sales by Type (2021-2032)
  4. 8.1.3 North America Etoposide Price by Type (2021-2032)
  5. 8.2 North America Etoposide Market Size by Application
  6. 8.2.1 North America Etoposide Revenue by Application (2021-2032)
  7. 8.2.2 North America Etoposide Sales by Application (2021-2032)
  8. 8.2.3 North America Etoposide Price by Application (2021-2032)
  9. 8.3 North America Etoposide Market Size by Country
  10. 8.3.1 North America Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Etoposide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Etoposide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Etoposide Market Size by Type
  2. 9.1.1 Europe Etoposide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Etoposide Sales by Type (2021-2032)
  4. 9.1.3 Europe Etoposide Price by Type (2021-2032)
  5. 9.2 Europe Etoposide Market Size by Application
  6. 9.2.1 Europe Etoposide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Etoposide Sales by Application (2021-2032)
  8. 9.2.3 Europe Etoposide Price by Application (2021-2032)
  9. 9.3 Europe Etoposide Market Size by Country
  10. 9.3.1 Europe Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Etoposide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Etoposide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Etoposide Market Size by Type
  2. 10.1.1 China Etoposide Revenue by Type (2021-2032)
  3. 10.1.2 China Etoposide Sales by Type (2021-2032)
  4. 10.1.3 China Etoposide Price by Type (2021-2032)
  5. 10.2 China Etoposide Market Size by Application
  6. 10.2.1 China Etoposide Revenue by Application (2021-2032)
  7. 10.2.2 China Etoposide Sales by Application (2021-2032)
  8. 10.2.3 China Etoposide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Etoposide Market Size by Type
  2. 11.1.1 Asia Etoposide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Etoposide Sales by Type (2021-2032)
  4. 11.1.3 Asia Etoposide Price by Type (2021-2032)
  5. 11.2 Asia Etoposide Market Size by Application
  6. 11.2.1 Asia Etoposide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Etoposide Sales by Application (2021-2032)
  8. 11.2.3 Asia Etoposide Price by Application (2021-2032)
  9. 11.3 Asia Etoposide Market Size by Country
  10. 11.3.1 Asia Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Etoposide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Etoposide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Etoposide Market Size by Type
  2. 12.1.1 SAMEA Etoposide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Etoposide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Etoposide Price by Type (2021-2032)
  5. 12.2 SAMEA Etoposide Market Size by Application
  6. 12.2.1 SAMEA Etoposide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Etoposide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Etoposide Price by Application (2021-2032)
  9. 12.3 SAMEA Etoposide Market Size by Country
  10. 12.3.1 SAMEA Etoposide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Etoposide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Etoposide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Etoposide Value Chain Analysis
  2. 13.1.1 Etoposide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Etoposide Production Mode & Process
  6. 13.2 Etoposide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Etoposide Distributors
  9. 13.2.3 Etoposide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst